TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30553077

Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (T-CBT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Telephone-delivered pain psychoeducational active control condition (T-Ed)
Number of subjects: 160
Study: 26965476

Group type: EXPERIMENTAL
Intervention: Teachers' Diploma Programme on Psychosocial Care, Support, and Protection (15-month long-distance learning program)
Number of subjects: 325
Study: 26210752

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 23739564

Group type: EXPERIMENTAL
Intervention: AutoFlow with SIMV
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (SIMV only)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Observation group (AutoFlow with SIMV)
Number of subjects: 48
Study: 21354122

Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg daily)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg daily)
Number of subjects: 2
Study: 18637324

Group type: EXPERIMENTAL
Intervention: Intensive counselling including use of feeding cups and showing pictures of severe early childhood caries and a dental model at four, six, nine, and 12 month visits.
Number of subjects: 132

Group type: COMPARATOR
Intervention: Brief counselling on the use of a feeding cup at 6 months and bottle weaning at nine and 12 months without photographs or dental models.
Number of subjects: 132
Study: 16010453

Group type: EXPERIMENTAL
Intervention: Natural mineral water with high mineral content
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (natural mineral water with low mineral content)
Number of subjects: 6
Study: 12967481

Group type: EXPERIMENTAL
Intervention: M-CSF administered group (group 1; 19 patients)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-M-CSF administered group (group 2; 20 patients)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: M-CSF + G-CSF group
Number of subjects: 39
Study: 10882962

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 8885185

Group type: EXPERIMENTAL
Intervention: Medical audit and feedback in study hospitals
Number of subjects: 2593

Group type: COMPARATOR
Intervention: Control hospital
Number of subjects: 2593
Study: 1382623

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 30 mg/kg body weight 1 1/2 hours before, and four and 12 hours after operation (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Methylprednisolone group (n = 6)
Number of subjects: 12
Study: 4005083

Group type: EXPERIMENTAL
Intervention: Indirect blood pressure measurement using a random zero sphygmomanometer
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intra-arterial blood pressure measurement using the Oxford system
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Post-exercise blood pressure measurement
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Systolic and diastolic blood pressure measurements during exercise
Number of subjects: 25
Study: 31821491

Group type: COMPARATOR
Intervention: Technique inspection
Number of subjects: 150

Group type: COMPARATOR
Intervention: Oral education
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 29427368

Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 54

Group type: COMPARATOR
Intervention: Adefovir
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: ALT flare
Number of subjects: 54
Study: 28437308

Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 26317254

Group type: EXPERIMENTAL
Intervention: Patients with AAA and ILT
Number of subjects: 157

Group type: COMPARATOR
Intervention: Patients with AAA without ILT
Number of subjects: 157
Study: 22882018

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800 mg once-daily for 12 weeks
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1200 mg once-daily for 12 weeks
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049
Study: 21247561

Group type: EXPERIMENTAL
Intervention: Modified Uchida technique
Number of subjects: 2198

Group type: COMPARATOR
Intervention: Silver clips
Number of subjects: 2198
Study: 18436169

Group type: EXPERIMENTAL
Intervention: Allevyn foam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Jellonet with proflavin-soaked cotton wool
Number of subjects: 60
Study: 16956332

Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 291

Group type: COMPARATOR
Intervention: Open colposuspension
Number of subjects: 291
Study: 15294385

Group type: EXPERIMENTAL
Intervention: BDI-high normal group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: BDI-low group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 11280555

Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg b.i.d. for 48 weeks
Number of subjects: 859

Group type: COMPARATOR
Intervention: Placebo b.i.d. for 48 weeks
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg b.i.d.
Number of subjects: 859

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 859
Study: 9308791

Group type: EXPERIMENTAL
Intervention: Fresh testicular spermatozoa (ICSI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Frozen-thawed testicular spermatozoa (ICSI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fresh testicular spermatozoa from non-obstructive azoospermia (ICSI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cultured testicular spermatozoa from obstructive azoospermia
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cultured testicular spermatozoa from non-obstructive azoospermia
Number of subjects: 20
Study: 8316770

Group type: EXPERIMENTAL
Intervention: Different training programs
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 3505604

Group type: EXPERIMENTAL
Intervention: Bulb syringe (BLB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: De Lee catheter (DL)
Number of subjects: 60
Study: 29853197

Group type: EXPERIMENTAL
Intervention: Customised titanium CRB omega miniplate
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional titanium miniplates
Number of subjects: 200
Study: 27621026

Group type: EXPERIMENTAL
Intervention: Surgical suppression of the oscillatory component of reflux
Number of subjects: 54
Study: 24319096

Group type: EXPERIMENTAL
Intervention: Clinical reminder to providers (intervention group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 89
Study: 22672481

Group type: EXPERIMENTAL
Intervention: Psychosocial risk screening and motivational interviewing intervention
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Youth friendly practice training (9 hours) and feedback
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Follow-up at 3 and 12 months post-consultation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison practices receive a three-hour seminar in youth friendly practice only
Number of subjects: 42
Study: 20924261

Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.3 or 0.5 mg) monthly + sham PDT
Number of subjects: 423

Group type: COMPARATOR
Intervention: PDT + monthly sham injection
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 423
Study: 18406949

Group type: EXPERIMENTAL
Intervention: Arthroscopic excision
Number of subjects: 72

Group type: COMPARATOR
Intervention: Open excision
Number of subjects: 72
Study: 16371522

Group type: EXPERIMENTAL
Intervention: Structured empathic attention
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation
Number of subjects: 236

Group type: COMPARATOR
Intervention: Patient-controlled analgesia with fentanyl and midazolam
Number of subjects: 236

Group type: COMPARATOR
Intervention: Standard care treatment
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Nonpharmacologic analgesia adjuncts
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Nonpharmacologic adjuncts
Number of subjects: 236
Study: 11356812

Group type: EXPERIMENTAL
Intervention: Active torso heating with clothing modifications
Number of subjects: 8

Group type: COMPARATOR
Intervention: Condition 1 (no torso heating)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Condition 2 (moderate torso heating)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Condition 3 (high torso heating)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Condition 4 (extreme torso heating)
Number of subjects: 8
Study: 9144368

Group type: EXPERIMENTAL
Intervention: rgp160 on a month 0, 1, 2, 3, 4, and 5 immunization schedule
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: rgp160 on a month 0, 1, 2, and 5 schedule
Number of subjects: 22

Group type: COMPARATOR
Intervention: alum/deoxycholate placebo
Number of subjects: 22

Group type: COMPARATOR
Intervention: licensed hepatitis B virus vaccine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: rgp160
Number of subjects: 22
Study: 7910155

Group type: EXPERIMENTAL
Intervention: nebivolol (5 mg o.i.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: atenolol (100 mg o.i.d.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: both drugs
Number of subjects: 24
Study: 3496284

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cotrimoxazole
Number of subjects: 40
Study: 29794482

Group type: EXPERIMENTAL
Intervention: ARB arm with conventional regimen plus ARB candesartan for the first 6 months (n = 40)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control arm with conventional regimen (TSP followed by oral prednisolone) (n = 37)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: ARB arm
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 77
Study: 26960255

Group type: EXPERIMENTAL
Intervention: Capabilities Model of Dementia Care (CMDC)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Usual long-term care (LTC)
Number of subjects: 129
Study: 22476441

Group type: EXPERIMENTAL
Intervention: QAE-P questionnaire
Number of subjects: 708
Study: 21727696

Group type: EXPERIMENTAL
Intervention: Common seborrheic keratosis (CSK)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Dermatosis papulosa nigra (DPN)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Pedunculated seborrheic keratoses (PSK)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Flat SK
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Stucco keratoses
Number of subjects: 250
Study: 19192368

Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Psychological treatment (patients referred by GP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Psychological treatment (patients recruited through systematic screening)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 15
Study: 16982961

Group type: EXPERIMENTAL
Intervention: Systolic BP (SBP)
Number of subjects: 1271

Group type: EXPERIMENTAL
Intervention: Diastolic BP (DBP)
Number of subjects: 1271

Group type: EXPERIMENTAL
Intervention: Mean BP (MBP)
Number of subjects: 1271

Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 1271
Study: 15309217

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 11

Group type: COMPARATOR
Intervention: MTX (Methotrexate)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (Healthy blood donors)
Number of subjects: 11
Study: 11555394

Group type: EXPERIMENTAL
Intervention: HAART combined with G-CSF thrice weekly for 12 weeks (n = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: HAART (n = 5)
Number of subjects: 11
Study: 9233703

Group type: EXPERIMENTAL
Intervention: Ganciclovir (GCV) + Acyclovir (ACV)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Acyclovir (ACV)
Number of subjects: 167
Study: 8292119

Group type: EXPERIMENTAL
Intervention: Lumpectomy followed by breast irradiation (50 Gy)
Number of subjects: 818

Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 818
Study: 3060987

Group type: EXPERIMENTAL
Intervention: Fish oil (4.8 g n‐3 PUFA's) for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vegetable oil (4.8 g n‐6 PUFA's) for 12 weeks
Number of subjects: 36
Study: 30095673

Group type: EXPERIMENTAL
Intervention: Disclosure to family members
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Total disclosure
Number of subjects: 121

Group type: COMPARATOR
Intervention: Disclosure to co-workers, friends, acquaintances, or religious groups
Number of subjects: 121
Study: 28751566

Group type: EXPERIMENTAL
Intervention: Long-asparaginase
Number of subjects: 1552

Group type: COMPARATOR
Intervention: Short-asparaginase
Number of subjects: 1552
Study: 25911859

Group type: EXPERIMENTAL
Intervention: 180 μg peginterferon alfa-2a
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 360 μg peginterferon alfa-2a
Number of subjects: 51
Study: 24004119

Group type: EXPERIMENTAL
Intervention: Low-dose helical computed tomography (CT)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Chest radiography
Number of subjects: 1000
Study: 21345776

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.33% delivered at 2 mL/h for 72 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline 0.9% delivered at 2 mL/h for 72 hours (Control)
Number of subjects: 15
Study: 18306871

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Serum physiologic
Number of subjects: 30
Study: 21092360

Group type: EXPERIMENTAL
Intervention: Active treatment arm in a RCT for CFS/ME
Number of subjects: 43
Study: 15653017

Group type: EXPERIMENTAL
Intervention: Distal Protection (DP) device
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-DP group
Number of subjects: 16
Study: 12472516

Group type: EXPERIMENTAL
Intervention: Cophenylcaine spray
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: No spray
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 90
Study: 9661597

Group type: EXPERIMENTAL
Intervention: Inferior petrosal sinus sampling (IPSS)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Imaging studies
Number of subjects: 37
Study: 7855782

Group type: EXPERIMENTAL
Intervention: Acenocoumarol
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Phenprocoumon
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Total INR assessments
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Method 3 (total observation time assuming INR changing linearly)
Number of subjects: 1700
Study: 2729123

Group type: EXPERIMENTAL
Intervention: Dilevalol (200, 400, and 800 mg for 5 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dilevalol
Number of subjects: 18
Study: 5312317

Group type: EXPERIMENTAL
Intervention: Twice-weekly regimen of high-dosage isoniazid plus streptomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once-weekly chemotherapy with high-dosage isoniazid plus streptomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once-weekly chemotherapy with high-dosage isoniazid plus streptomycin plus high-dosage pyrazinamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial daily phase of 4 weeks with moderate dosage of isoniazid plus streptomycin followed by once-weekly high-dosage isoniazid plus streptomycin
Number of subjects: 0
Study: 31122678

Group type: EXPERIMENTAL
Intervention: Structured virtual reality curriculum for laparoscopic appendicectomy (LA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-fidelity VR simulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 60
Study: 29399314

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) in conjunction with 100 mg carbamazepine (administered at baseline and after 2 days) for 9 sessions (3 days a week).
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham laser in conjunction with 100 mg carbamazepine (administered at baseline and after 2 days) for 9 sessions (3 days a week).
Number of subjects: 30
Study: 28707810

Group type: EXPERIMENTAL
Intervention: 3.75-mg GnRHa
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1.88-mg GnRHa
Number of subjects: 50
Study: 25680817

Group type: EXPERIMENTAL
Intervention: Metyrapone (1 g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 23619725

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope (McL) with chest compressions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: AWS (Pentax-AWS Airwayscope) with chest compressions
Number of subjects: 18
Study: 20582425

Group type: EXPERIMENTAL
Intervention: IMN plus misoprostol
Number of subjects: 290

Group type: COMPARATOR
Intervention: misoprostol plus placebo
Number of subjects: 290
Study: 18813182

Group type: COMPARATOR
Intervention: Lercanidipine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lercanidipine and antioxidants (Vitamins C and E)
Number of subjects: 16
Study: 16543714

Group type: EXPERIMENTAL
Intervention: Paricalcitol (TIW)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Paricalcitol (QD)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (TIW)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (QD)
Number of subjects: 220
Study: 14526263

Group type: EXPERIMENTAL
Intervention: Mixed AA solution infusion at low rate (2 mg/min/kg BW)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mixed AA solution infusion at high rate (4.5 mg/min/kg BW)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isotonic saline infusion (control)
Number of subjects: 8
Study: 11070529

Group type: EXPERIMENTAL
Intervention: Short-term alcohol-focused intervention (six 1-hour sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 32
Study: 8982557

Group type: EXPERIMENTAL
Intervention: Cuprophane dialyzer
Number of subjects: 36

Group type: COMPARATOR
Intervention: Polymethylmethacrylate (PMMA) dialyzer
Number of subjects: 36
Study: 1468827

Group type: EXPERIMENTAL
Intervention: Continuous 48-h infusion of calcitonin gene-related peptide (n = 6)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Two successive 8-h infusions of calcitonin gene-related peptide (n = 5)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Continuous 48-h infusion of calcitonin gene-related peptide
Number of subjects: 11
Study: 6742081

Group type: EXPERIMENTAL
Intervention: d-timolol
Number of subjects: 34

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study: 29996735

Group type: EXPERIMENTAL
Intervention: Thigh angular velocity ratios
Number of subjects: 21
Study: 27742624

Group type: EXPERIMENTAL
Intervention: Focused ultrasound examination (f‐US) of the heart and lungs performed by emergency physicians (EP) as soon as the patient arrives to the emergency department (ED)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard diagnostic evaluation by the EP
Number of subjects: 288
Study: 26557703

Group type: EXPERIMENTAL
Intervention: Family‐ and safety‐supportive supervisor behavior training (computer‐based), followed by two weeks of behavior tracking and a four‐hour, facilitated team effectiveness session including supervisors and employees.
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Family‐and safety‐supportive supervisor behavior training (computer‐based), followed by two weeks of behavior tracking and a four‐hour, facilitated team effectiveness session including supervisors and employees.
Number of subjects: 264
Study: 23053266

Group type: EXPERIMENTAL
Intervention: Combinational therapy (vinorelbine and capecitabine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sequential therapy (vinorelbine followed by capecitabine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combinational therapy (vinorelbine and capecitabine) in patients with liver metastases
Number of subjects: 60
Study: 20968019

Group type: EXPERIMENTAL
Intervention: Combined photon-neutron radiotherapy (CPNT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 31
Study: 18233965

Group type: EXPERIMENTAL
Intervention: Ventricular premature complex (VPC)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Short-long-short (SLS) sequence
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Patients with SLS only
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Patients with VPC only
Number of subjects: 29

Group type: COMPARATOR
Intervention: ECG parameters
Number of subjects: 29
Study: 16608061

Group type: EXPERIMENTAL
Intervention: 3-D texture classification using adaptive multiple feature method (AMFM)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 2-D texture classification using adaptive multiple feature method (AMFM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 3-D classification of NN vs NS
Number of subjects: 34

Group type: COMPARATOR
Intervention: 2-D classification of NN vs NS
Number of subjects: 34
Study: 15214555

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (40 patients randomized)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Right-left ductal shunt
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Left-right ductal shunt
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Left-right atrial shunt
Number of subjects: 85
Study: 11702913

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 8
Study: 9209202

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 8129324

Group type: EXPERIMENTAL
Intervention: Proparacaine HCl 0.5% eye drops
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal saline eye drops
Number of subjects: 55
Study: 3620098

Group type: COMPARATOR
Intervention: Ethanol (0 g/kg, 0.12 g/kg, 0.6 g/kg, 1.05 g/kg lean body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol (higher doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 0
Study: 30962103

Group type: EXPERIMENTAL
Intervention: EGCG (5-7 mg/kg/day) + Cognitive Training (CT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo + Cognitive Training (CT)
Number of subjects: 27